Connor, Clark & Lunn Investment Management Ltd. Mirati Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$27.8 - $45.35 $2.07 Million - $3.38 Million	-74,502 Reduced 63.59%	42,649 $1.86 Million
Q2 2023 Aug 10, 2023	SELL	$36.13 - $49.49 $698,573 - $956,889	-19,335 Reduced 14.17%	117,151 $4.23 Million
Q1 2023 May 09, 2023	BUY	$36.54 - $54.26 $4.99 Million - $7.41 Million	136,486 New	136,486 $5.07 Million
Q1 2022 May 12, 2022	SELL	$75.82 - $150.97 $1.57 Million - $3.13 Million	-20,751 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $2.74 Million - $3.95 Million	20,751 New	20,751 $3.04 Million
Q2 2021 Aug 12, 2021	SELL	$144.0 - $179.73 $640,512 - $799,439	-4,448 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$158.92 - $221.61 $228,050 - $318,010	1,435 Added 47.63%	4,448 $762,000
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $488,256 - $723,933	3,013 New	3,013 $662,000
Q3 2017 Nov 14, 2017	SELL	$4.7 - $11.7 $74,730 - $186,030	-15,900 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	15,900	15,900 $58,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account